The FDA has granted 510(k) clearance to Medtronic for its MiniMed “Go Smart” multiple daily injection system — the first ...
The MiniMed Go™ system is cleared for individuals with insulin-requiring type 1 and type 2 diabetes aged 7 years and older, ...
Medtronic has received US Food and Drug Administration (FDA) 510 (k) clearance for its MiniMed Go Smart MDI system, a ...
Medtronic said Monday it received 510 (k) clearance from the Food and Drug Administration for an app to connect its smart ...
The FDA has cleared a mobile application that will connect with a next-generation multiple daily injection automated insulin ...
Medtronic Diabetes has expanded U.S. pharmacy formulary access for its MiniMed 780F insulin pump through agreements with ...
GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones ...
Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced the U.S. Food ...
In a phase IIIb trial of adults with active psoriatic arthritis (PsA) and obesity or overweight, adding the GLP-1 drug ...